ASSESSING THE IMPLEMENTABILITY OF REGULATORY AGENCIES' GUIDANCE ON DIVERSITY IN CLINICAL TRIALS

被引：0
|
作者：
Metcalfe, R. [1 ]
Reshef, S. [2 ]
Park, J. [1 ]
机构：
[1] Core Clin Sci, Vancouver, BC, Canada
[2] Teva Branded Pharmaceut Prod R&D Inc, Epidemiol & Global Hlth Econ & Outcomes Res, Parsippany, NJ USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HPR87
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [21] Comparison of ocriplasmin efficacy and treatment guidance as determined by Fiduropean regulatory agencies
    Korobelnik, J.
    ACTA OPHTHALMOLOGICA, 2014, 92
  • [22] Development and delivery of clinical pharmacology in regulatory agencies
    Breckenridge, Alasdair
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (06) : 866 - 869
  • [23] Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example
    Aroda, Vanita R.
    Saugstrup, Trine
    Buse, John B.
    Donsmark, Morten
    Zacho, Jeppe
    Davies, Melanie J.
    DIABETES OBESITY & METABOLISM, 2019, 21 (10): : 2203 - 2210
  • [24] Request for regulatory guidance for cancer cachexia intervention trials
    Fearon, K. C. H.
    Argiles, J. M.
    Baracos, V. E.
    Bernabei, R.
    Coats, A. J. S.
    Crawford, J.
    Deutz, N. E.
    Doehner, W.
    Evans, W. J.
    Ferrucci, L.
    Garcia, J. M.
    Gralla, R. J.
    Jatoi, A.
    Kalantar-Zadeh, K.
    Lainscak, M.
    Morley, J. E.
    Muscaritoli, M.
    Polkey, M. I.
    Rosano, G.
    Rossi-Fanelli, F.
    Schols, A. M.
    Strasser, F.
    Vellas, B.
    von Haehling, S.
    Anker, S. D.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2015, 6 (04) : 272 - 274
  • [25] Regulatory TEVAR clinical trials
    Garcia-Toca, Manuel
    Eskandari, Mark K.
    JOURNAL OF VASCULAR SURGERY, 2010, 52 : 22S - 25S
  • [26] Understanding the Medical Dictionary for Regulatory Activities for Assessing Safety in Atopic Dermatitis Clinical Trials
    Chang, Michelle J. J.
    Kontzias, Christina L.
    Pixley, Jessica N.
    Feldman, Steven R.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2023, 27 (03) : 285 - 285
  • [27] Rhinosinusitis: Developing guidance for clinical trials
    Meltzer, Eli O.
    Hamilos, Daniel L.
    Hadley, James A.
    Lanza, Donald C.
    Marple, Bradley F.
    Nicklas, Richard A.
    Adinoff, Allen D.
    Bachert, Claus
    Borish, Larry
    Chinchilli, Vernon M.
    Danzig, Melvyn R.
    Ferguson, Berrylin J.
    Fokkens, Wytske J.
    Jenkins, Stephen G.
    Lund, Valerie J.
    Mafee, Mahmood F.
    Naclerio, Robert M.
    Pawankar, Ruby R.
    Ponikau, Jens U.
    Schubert, Mark S.
    Slavin, Raymond G.
    Stewart, Michael G.
    Togias, Alkis
    Wald, Ellen R.
    Winther, Birgit
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (05) : S17 - S61
  • [28] Rhinosinusitis: Developing guidance for clinical trials
    Meltzer, Eli O.
    Hamilos, Daniel L.
    Hadley, James A.
    Lanza, Donald C.
    Marple, Bradley F.
    Nicklas, Richard A.
    Adinoff, Allen D.
    Bachert, Claus
    Borish, Larry
    Chinchilli, Vernon M.
    Danzig, Melvyn R.
    Ferguson, Berrylin J.
    Fokkens, Wytske J.
    Jenkins, Stephen G.
    Lund, Valerie J.
    Mafee, Mahmood F.
    Naclerio, Robert M.
    Pawankar, Ruby
    Ponikau, Jens U.
    Schubert, Mark S.
    Slavin, Raymond G.
    Stewart, Michael G.
    Togias, Alkis
    Wald, Ellen R.
    Winther, Birgit
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2006, 135 (05) : S31 - S80
  • [29] DIVERSITY IN CLINICAL TRIALS: LIFE SCIENCE INITIATIVES AND CHALLENGES IN LIGHT OF THE FDA'S LATEST GUIDANCE
    Andrews, M.
    Marsh, M.
    Walters, D.
    King, A.
    Daou, S.
    VALUE IN HEALTH, 2024, 27 (06) : S265 - S265
  • [30] Assessing Compliance and Diversity in Early Phase Radiation Oncology Clinical Trials in the United States
    Rezaei, S. A.
    Price, A. T.
    McClelland, S., III
    Henke, L. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E59 - E59
12345